Through Crowdberry, you have the opportunity to invest in the Slovak network of private pharmacies, clinics, and polyclinics Váš Lekár, which provides high-quality and affordable healthcare with an emphasis on prevention, modern technologies, and efficiently set processes.

If you are still unsure about investing in the Váš Lekár investment opportunity, watch the recording of the Q&A webinar, where you can find answers to all the important questions that concern investors.

Take advantage of the opportunity to invest in the modern healthcare network Váš Lekár, trusted by more than 500 investors who have already allocated more than €2.3 million.

News you learned about in the webinar

✅ The signing of a clinical trial agreement with an international pharmaceutical company is expected within the next two weeks.

✅ Instead of one, two clinical trials will run in parallel.

✅ Four other entities have expressed interest in collaborating on clinical trials.

✅ Peter Potuček, CEO, and management Váš Lekár plans to add one new clinical trial every quarter since the launch of the first study, which will generate revenues beyond the original business plan.

The webinar was led by Crowdberry partners Dano Gašpar and Michal Nešpor.